Freestyle libre flash glucose self-monitoring system a single-technology assessment
Adequate treatment management, aimed at tight control of blood glucose, reduces the risk of the long-term complications of diabetes such as retinopathy, nephropathy, neuropathy, coronary heart disease, ischaemic stroke and peripheral vascular disease. "Management" of the disease should be...
| Main Authors: | , , , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Oslo
Norwegian Institute of Public Health, Division for Health Services
2017, August 2017
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Adequate treatment management, aimed at tight control of blood glucose, reduces the risk of the long-term complications of diabetes such as retinopathy, nephropathy, neuropathy, coronary heart disease, ischaemic stroke and peripheral vascular disease. "Management" of the disease should be understood as a package including testing of blood glucose, taking insulin (i.e., multiple daily insulin injections, using an insulin pump), using anti-hyperglycemic drugs, or adopting lifestyle interventions such as diet and physical activity. In recent years, and available in Europe since 2014, the FreeStyle Libre System -- a "wireless" method using a sensor for monitoring interstitial fluid glucose -- The clinical effectiveness of FreeStyle Libre needs to be investigated in different conditions, for example, among individuals with poor self-monitoring adherence, newly diagnosed, impaired awareness of hypoglycaemia, and in addition to training and education components.4. FreeStyle Libre compared to other continuous monitoring systems is warranted.5. Pain is a major determinant of diabetes treatment adherence, especially for children, and it should be included as an individual outcome in future trials.6. Future trials should include longer term follow up and quality of life outcome assessments at various points to inform improved clinical and cost effectiveness modelling BACKGROUND: Diabetes mellitus (DM) has become one of the most common public health problems world-wide. According to the 2014 Norwegian Public Health report, diabetes affects an estimated 4.3% of the Norwegian population. Diabetes is a metabolic disorder resulting from a defect in insulin production, secretion, action, or all. Type 1 and 2 are the two main types, with the prevalence of type 2 accounting for the majority (>85%) of diabetes. This assessment will focus on FreeStyle Libre, flash glucose monitor for insulin treated individuals with type 1 and 2 diabetes ("Type 1 and 2 DM"). To achieve proper quality of life and reduce long-term problems, people are increasingly encouraged to take an active role in the management of their condition. was introduced to help individuals with type 1 and 2 DM achieve better glucose control. The system, unlike others, does not require finger prick calibration, since that functionality is embedded into the core technology. Also, unlike other systems, the individual has to take active action to get access to the real time glucose value, by leading the receiver over the sensor. Similarly to other continuous glucose monitoring options, it relies on the individual to take action on the information retrieved. SUGGESTED RESEARCH PRIORITIES: 1. Independent research for FreeStyle Libre will be important.2. Diabetes affects the life of children, adolescents and their caregivers in many ways, as well as pregnant women. Independent research including these groups is warranted.3. |
|---|---|
| Item Description: | "Report 2017" |
| Physical Description: | 1 PDF file (105 pages) illustrations |
| ISBN: | 9788280828521 |